150 related articles for article (PubMed ID: 23503793)
1. [UroLift®: an operative non-ablative procedure for treatment of benign prostatic syndrome].
Berges R; Sievert KD; Gratzke C; Wetterauer U
Urologe A; 2013 Mar; 52(3):350-3. PubMed ID: 23503793
[TBL] [Abstract][Full Text] [Related]
2. Minimally invasive treatment for lower urinary tract symptoms due to benign prostatic hyperplasia. Our initial experience with Urolift® under local anaesthesia and sedation.
Cayuelas Rubio C; Pallás Costa Y; Juan Escudero J; Ramos de Campo M; García Ibáñez J; Mitjana Biosca S; Monzó Cataluña A; Rechi Sierra K; Fernández Arjona M; López Alcina E
Actas Urol Esp (Engl Ed); 2019 Nov; 43(9):488-494. PubMed ID: 31160158
[TBL] [Abstract][Full Text] [Related]
3. Prospective, randomized, multinational study of prostatic urethral lift versus transurethral resection of the prostate: 12-month results from the BPH6 study.
Sønksen J; Barber NJ; Speakman MJ; Berges R; Wetterauer U; Greene D; Sievert KD; Chapple CR; Montorsi F; Patterson JM; Fahrenkrug L; Schoenthaler M; Gratzke C
Eur Urol; 2015 Oct; 68(4):643-52. PubMed ID: 25937539
[TBL] [Abstract][Full Text] [Related]
4. The role of novel minimally invasive treatments for lower urinary tract symptoms associated with benign prostatic hyperplasia.
Madersbacher S; Roehrborn CG; Oelke M
BJU Int; 2020 Sep; 126(3):317-326. PubMed ID: 32599656
[TBL] [Abstract][Full Text] [Related]
5. Prostatic Urethral Lift: A New Minimally Invasive Treatment for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.
Bozkurt A; Karabakan M; Keskin E; Hirik E; Balci MB; Nuhoglu B
Urol Int; 2016; 96(2):202-6. PubMed ID: 26613256
[TBL] [Abstract][Full Text] [Related]
6. Usage of GreenLight HPS 180-W laser vaporisation for treatment of benign prostatic hyperplasia.
Jovanović M; Džamić Z; Aćimović M; Kajmaković B; Pejčić T
Acta Chir Iugosl; 2014; 61(1):57-61. PubMed ID: 25782227
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of the urolift® system for the treatment of benign prostate hyperplasia symptoms: systematic review.
Sánchez-Gómez LM; Polo-deSantos M; Gómez-Sancha F; Luengo-Matos S
Actas Urol Esp; 2015 Jun; 39(5):311-9. PubMed ID: 25260950
[TBL] [Abstract][Full Text] [Related]
8. Emerging Minimally Invasive Treatment Options for Male Lower Urinary Tract Symptoms.
Magistro G; Chapple CR; Elhilali M; Gilling P; McVary KT; Roehrborn CG; Stief CG; Woo HH; Gratzke C
Eur Urol; 2017 Dec; 72(6):986-997. PubMed ID: 28734706
[TBL] [Abstract][Full Text] [Related]
9. [The UroLift® system for treatment of the benign prostatic syndrome (BPS)].
Westhofen T; Magistro G; Stief C; Gratzke C
Aktuelle Urol; 2018 Dec; 49(6):515-518. PubMed ID: 30522162
[TBL] [Abstract][Full Text] [Related]
10. [Management of geriatric patients with benign prostatic hyperplasia].
Becher KF; Madersbacher S; Michel MC; Olbert P
Urologe A; 2020 Oct; 59(10):1195-1203. PubMed ID: 32880664
[TBL] [Abstract][Full Text] [Related]
11. Benign prostatic hyperplasia: an update on minimally invasive therapy including Aquablation.
Das AK; Han TM; Uhr A; Roehrborn CG
Can J Urol; 2020 Aug; 27(S3):2-10. PubMed ID: 32875996
[TBL] [Abstract][Full Text] [Related]
12. [Are the UroLift(®) implants an alternative for the treatment of benign prostatic hyperplasia? Short-term results and predictive factors of failure].
Beurrier S; Peyromaure M; Belas O; Barry Delongchamps N
Prog Urol; 2015 Jul; 25(9):523-9. PubMed ID: 25934591
[TBL] [Abstract][Full Text] [Related]
13. [Diagnosis and Minimal Invasive Treatment of Benign Prostatic Hyperplasia].
Kobe A; Donati O; Pfammatter T
Ther Umsch; 2020; 77(2):53-56. PubMed ID: 32633228
[TBL] [Abstract][Full Text] [Related]
14. Prostatic arterial embolization for the treatment of lower urinary tract symptoms due to large (>80 mL) benign prostatic hyperplasia: results of midterm follow-up from Chinese population.
Wang MQ; Guo LP; Zhang GD; Yuan K; Li K; Duan F; Yan JY; Wang Y; Kang HY; Wang ZJ
BMC Urol; 2015 Apr; 15():33. PubMed ID: 25887036
[TBL] [Abstract][Full Text] [Related]
15. UroLift in Place of Fiducial Markers for Patients With Benign Prostatic Hyperplasia Undergoing External Beam Radiation Therapy.
Keehn A; Fram E; Garg M; Maria P
Urology; 2017 Jun; 104():230-234. PubMed ID: 27988266
[TBL] [Abstract][Full Text] [Related]
16. [Benign prostatic hyperplasia : New and treatment-relevant aspects from the DGU guidelines].
Bach T; Heitz M; Bruns T
Urologe A; 2020 May; 59(5):544-549. PubMed ID: 32274543
[TBL] [Abstract][Full Text] [Related]
17. [Prostatic urethral lift using Urolift® system for benign prostatic hyperplasia: 7years experience].
Userovici M; Ochoa A; Anract J; Beurrier S; Peyromaure M; Barry Delongchamps N
Prog Urol; 2020 Mar; 30(3):147-154. PubMed ID: 32127310
[TBL] [Abstract][Full Text] [Related]
18. Internal Iliac Artery Embolization for Benign Prostatic Hyperplasia? First Read the Fine Print.
Uflacker AB; Haskal ZJ
J Vasc Interv Radiol; 2015 Sep; 26(9):1311-2. PubMed ID: 26314640
[No Abstract] [Full Text] [Related]
19. UroLift system for relief of prostate obstruction under local anesthesia.
Barkin J; Giddens J; Incze P; Casey R; Richardson S; Gange S
Can J Urol; 2012 Apr; 19(2):6217-22. PubMed ID: 22512970
[TBL] [Abstract][Full Text] [Related]
20. Can the UroLift prostatic implant device treat the symptoms of benign prostatic hypertrophy, avoid sexual dysfunction and reduce hospital TURP waiting times? A single centre, single surgeon experience and review of the literature.
Bardoli AD; Taylor WSJ; Mahmalji W
Aging Male; 2017 Sep; 20(3):192-197. PubMed ID: 28609136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
